Correlation Between X4 Pharmaceuticals and United Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and United Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and United Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and United Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between XFOR and United is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and United Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and United Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.67 times less return on investment than United Therapeutics. In addition to that, X4 Pharmaceuticals is 7.44 times more volatile than United Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. United Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 35,258 in United Therapeutics on August 24, 2024 and sell it today you would earn a total of 1,478 from holding United Therapeutics or generate 4.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. United Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| United Therapeutics |
X4 Pharmaceuticals and United Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and United Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |